Skip to main content

Zinplava

bezlotoxumab
Used for Bacterial Infection

Zinplava (bezlotoxumab) is a medication used to prevent repeat infection from a bacteria called Clostridioides difficile (C. diff). It's given as an injection into the veins for one dose only.

Reviewed by:Last reviewed on August 19, 2022
basics-icon

What is Zinplava (bezlotoxumab)?

What is Zinplava (bezlotoxumab) used for?

  • Prevention of another C. diff infection (CDI) in high-risk adults who are taking antibiotics for CDI

How Zinplava (bezlotoxumab) works

Zinplava (bezlotoxumab) is an antibody (a type of protein). It attaches to a toxin that the C. diff bacteria releases into your body and neutralizes it.

Drug facts

Common BrandsZinplava
Drug ClassBiologic
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only
side-effects-icon

Side effects of Zinplava (bezlotoxumab)

The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common Side Effects

  • Nausea (7%)
  • Fever (5%)
  • Headache (4%)

Less Common Side Effects

  • Infusion-related reaction (e.g., feeling tired, dizziness, shortness of breath)

Zinplava (bezlotoxumab) serious side effects

Contact your healthcare provider immediately if you experience any of the following.

  • Heart failure: shortness of breath, wheezing, swelling, tired, confusion, faster heart rate

Source: DailyMed

The following Zinplava (bezlotoxumab) side effects have also been reported

Side effects that you should report to your care team as soon as possible:

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

pros-and-cons-icon

Pros and cons of Zinplava (bezlotoxumab)

Pros

  • Works well to prevent CDIs
  • Given as a single dose
  • No known drug interactions

Cons

  • Only used for preventing CDI from happening again (not for treatment)
  • Given as an IV injection by a healthcare provider
  • Brand name only, so might be expensive
pharmacist-tips-icon

Pharmacist tips for Zinplava (bezlotoxumab)

pharmacist
  • Zinplava (bezlotoxumab) doesn't take the place of your antibiotic treatment for CDI. Make sure to continue to take your antibiotic(s) as prescribed to you.
  • Mark on your calendar your appointment to see your provider and receive your Zinplava (bezlotoxumab) dose.
  • Before receiving Zinplava (bezlotoxumab), be sure to tell your provider about your medical conditions, especially if you have heart failure.
  • Tell your provider if you're pregnant or breastfeeding. It isn't known if Zinplava (bezlotoxumab) will harm your baby if taken during pregnancy or if it passes into breast milk. Discuss the risks and benefits of this medication with your provider.
faq-icon

Common questions about Zinplava (bezlotoxumab)

C. diff is a type of bacteria that causes severe diarrhea and inflammation of the colon. If severe enough, a CDI can be fatal. Your risk for CDI is higher if you are 65 years or older, have a weakened immune system, have had a previous CDI, have recently stayed in the hospital or at a nursing home, or take antibiotics. It's important for you to receive Zinplava (bezlotoxumab) if your provider orders it for you, because it's used to lower your risk of getting a CDI again.

You can still take antibiotics for a bacterial infection, even if you've had CDI before. The risk of developing CDI from antibiotics isn't the same; some antibiotics have a higher risk of causing CDI than others. If you have an infection and need an antibiotic(s), make sure to tell your provider that you've had a CDI before so they can pick the safest antibiotic for your infection.

No, Zinplava (bezlotoxumab) is a single-dose medication given as an IV infusion over 1 hour. You'll need to go to an infusion center, clinic, or hospital to receive your dose.

No, Zinplava (bezlotoxumab) can only be used to prevent a future CDI. It's for people who are already taking antibiotics for a CDI but are at high risk of getting another infection. It's important for you to continue your antibiotic treatment for CDI as prescribed, even if your provider ordered Zinplava (bezlotoxumab) for you.

educational-icon

How to save using GoodRx

Compare Prices
1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
Select your free coupon
2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
Show coupon to your pharmacist
3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
Get free couponLearn more
warnings-icon

Risks and warnings for Zinplava (bezlotoxumab)

Zinplava (bezlotoxumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.

Heart failure

  • Risk factors: History of heart failure

Zinplava (bezlotoxumab) can raise the risk of heart failure symptoms, especially if you have a history of heart failure. People with this heart problem should use Zinplava (bezlotoxumab) only if it's clearly needed. Before starting Zinplava (bezlotoxumab), make sure to tell your provider if you have heart failure. Contact your provider if you experience difficulty breathing, coughing or wheezing, swelling in your legs or ankles, low appetite, or if you get tired more easily after receiving Zinplava (bezlotoxumab). Your provider can check for heart failure through certain tests.

dosage-icon

Zinplava (bezlotoxumab) dosage

Typical dosage for Zinplava (bezlotoxumab)

The typical dose is 10 mg/kg of body weight given as a single injection into the veins (intravenous, or IV) over 1 hour.

Get savings updates for Zinplava (bezlotoxumab)

Receive price alerts, news, and other messages from GoodRx about Zinplava (bezlotoxumab) and other healthcare topics and relevant savings offers.

By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men's health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.